By: Sara Radcliffe CLSA President & CEO November 29, 2017 New CLSA/PwC 2018 Life Sciences Industry Report Confirms California is #1 Leader in Life Sciences Innovation On Nov. 15, CLSA and PwC unveiled the 2018 California Life Sciences Industry Report with a nationwide webinar and media launch. The 2018 report once again confirms that … Continue reading CLSA 2018 Industry Report, 14th Annual Pantheon Awards, Upcoming Events, New Members and More!
The CLSI CARB-X team – Heather Shane, Steve Karp, and Amy Xu – hosted Powered by CARB-X company, Proteus IRC, for an intensive strategy session designed to help Proteus transition from a research consortium to a VC-backed entity. The three-day session drew 22 volunteer advisors from 20 different organizations – from as far as Washington, … Continue reading CLSI CARB-X Hosts Intensive Strategy Session for “Powered by CARB-X” Proteus IRC
Heather Shane, Executive Director of the California Life Sciences Institute’s (CLSI) CARB-X Accelerator, spoke in November on two occasions about CARB-X and CLSI’s role in helping to move companies that are addressing the problem of Antimicrobial Resistance (AMR) through the product development pipeline. Her first appearance was at BARDA Industry Days in Washington, DC, where … Continue reading CLSI Participates in BARDA Industry Days and the One Nucleus Leadership Seminar – Addressing Infectious Disease Challenges
November 2017 Read the latest in FAST and Fellows news: Encellin’s (FAST Spring 2017) insulin-releasing implant for Type-1 Diabetes featured on NPR Read More LogicInk (FAST Spring 2017) announced their first product, LogicInk UV, an electronics-free temporary wearable powered by programmable ink Read More Eidos Therapeutics (FAST Spring 2016) initiates Phase 1 trial of AG10, … Continue reading FAST & Fellows Round Up
Powered by CARB-X company Spero plans for $75M IPO for November 2nd (SPRO) Read More Inhibrx Wins CARB-X Award of up to $6.0M to Accelerate Development of its Novel Antibody, INBRX-111, to Treat Pseudomonas Infections Read More CARB-X backs Integrated Biotherapeutics to accelerate the development of a novel toxoid-based vaccine to prevent drug-resistant MRSA infections … Continue reading CARB-X Updates November 2017
Resourceful HR ranked 52nd on the Puget Sound Business Journal’s (PSBJ) 2017 fastest-growing private companies list for Washington State, having made the list for the second year!
In 2011, the City of South San Francisco approved a redevelopment plan for the Oyster Point area. The Oyster Point Specific Plan called for 81 acres east of Highway 101 to be developed with new life sciences companies, upgrades to the marina and a potential hotel.
Congress is currently advancing legislation in both chambers to significantly overhaul the U.S. tax code. Historically, CLSA has focused our tax-related advocacy efforts around: (1) calling for an update and making permanent of the R&D Tax Credit, (2) protecting the Orphan Drug Tax Credit (ODTC), and (3) opposing the creation of and later calling for a repeal of the medical device tax.
Riffyn’s cloud-based R&D software connects previously siloed data to deliver reproducible science ready for machine learning.
The Independent Payment Advisory Board (IPAB) is a controversial advisory board enacted as part of the Affordable Care Act in 2010, which threatens seniors’ care and could harm biomedical innovation by reducing incentives for investment in new research and product development.